Alphapharm Pty Ltd v Beecham Group Plc [2001] FCA 713
Respondents should be given a reasonable opportunity to file any cross-claim alleging infringement; if not filed within the specified reasonable time, infringement proceedings must be commenced separately and will not delay the revocation proceeding.
- Parties
- Applicant: Alphapharm Pty Ltd; First Respondent: Beecham Group Plc; Second Respondent: SmithKline Beecham PLC; Third Respondent: SmithKline Beecham (Australia) Pty Ltd
- Jurisdiction
- Australia
- Judgment Date
- 13 June 2001
- Procedural Posture
- Patent Revocation / Interlocutory Directions Order
- Outcome
- interlocutory directions for further submissions and possible cross-claims
- Legal Topics
- Patent Validity, Patent Revocation, Cross Claims, Costs
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Alphapharm Pty Ltd
Applicant
Beecham Group Plc
First Respondent
SmithKline Beecham PLC
Second Respondent
SmithKline Beecham (Australia) Pty Ltd
Third Respondent
Procedural Posture
Patent Revocation / Interlocutory Directions Order
Legal Issues
- 1 Whether respondents should be permitted to file a cross-claim alleging patent infringement.
- 2 When costs thrown away by amendments should be taxed.
Ratio Decidendi
Respondents should be given a reasonable opportunity to file any cross-claim alleging infringement; if not filed within the specified reasonable time, infringement proceedings must be commenced separately and will not delay the revocation proceeding.
Court Disposition
interlocutory directions for further submissions and possible cross-claims
Orders
- Directions to be made on Friday 15 June 2001 in accordance with the short minutes proposed by Alphapharm unless further submissions are made by respondents concerning the date for filing any cross-claim by that time.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment